Mesa Laboratories, Inc. (MLAB) fair value analysis
Nasdaq · Updated 2026-10-26
MLAB price how computed
Forward Fair Value verdict
Fairly valuedMLAB is trading at within about 10% of estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $128.66
- Sector
- Technology
- 12-month range
- $70.60–$142.23
- Market cap
- $720M
- From 52-week high
- -9.5%
- Shares outstanding
- 5.6M
- Rank in Technology by discount to fair value
- #89 of 182
Last price is our stored weekly price from 2026-10-23, older than the 2026-10-26 run that built this page; the chart runs through 2026-10-23.
Mesa Laboratories, Inc. is a technology company that specializes in providing products and services for sterilization validation and monitoring, as well as biological and chemical indicators used in healthcare and industrial settings. The company operates globally, serving customers across medical device manufacturing, pharmaceutical, and healthcare industries.
MLAB currently ranks #89 of 182 Technology stocks by discount to fair value. Its Fairly valued verdict is new as of this week's run.
Fundamentals (4 quarters) how computed
- Market cap
- $720M
- P/E (trailing)
- 16x
- Revenue (TTM)
- $250M
- Net margin
- 1.9%
- EPS (TTM)
- $7.91
- Gross margin
- 64.9%
- Debt / equity
- 0.54
- Revenue growth (3-yr avg)
- 4.4%
- Shares outstanding
- 5.6M
Derived indicators how computed
- Quality grade
- B
- Margin trend
- Expanding
- 52-week position
- The top quarter of its range
- DCF cross-check
- Overvalued
Technicals how computed
- RSI (14-day)
- 44 · neutral
- 50-day average
- $126.70
- 200-day average
- $103.02
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Dividends how computed
- Paid, last 12 months
- $0.64 per share (4 payments)
- Yield on last price
- 0.50%
- Consecutive years of increases
- 0 (no streak on complete calendar years)
- Next ex-dividend date
- 2026-11-30
- Last payment date
- 2026-09-15
Earnings how computed
- Next earnings report
- 2026-11-05
- Last 8 quarters vs consensus
- 5 beat, 3 missed
- Quarter by quarter
- 2026-06 ▼ miss (-13.3%)
2026-03 ▲ beat (+31.5%)
2025-12 ▲ beat (+19.7%)
2025-09 ▲ beat (+35.3%)
2025-06 ▼ miss (-13.0%)
2025-03 ▲ beat (+17.8%)
2024-12 ▼ miss (-47.7%)
2024-09 ▲ beat (+56.5%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 1 buy · 2 hold · 0 sell (3 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $125
- Target vs last price
- -2.8%
What our data shows for MLAB
- Our model validated 17 trailing price-to-earnings windows for MLAB, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $70.60–$142.23.
- The 14-day relative strength index sits at a neutral 44.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MLAB
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent MLAB news
TickrTrends' derived news-sentiment signal for MLAB is currently leaning positive, computed from recent coverage.
- WASATCH ADVISORS LP Boosts Mesa Laboratories Inc (MLAB) Stake -- Shares Look 19% Overvalued on GF Value (gurufocus.com, 2026-10-15)
TickrTrends take: Wasatch Advisors LP's recent increase in its Mesa Laboratories position contrasts with the GF Value assessment suggesting the stock trades at a 19% premium to intrinsic worth, creating a divergence between institutional buying activity and fundamental valuation metrics. TickrTrends currently rates MLAB as fairly valued, positioning the stock between the more bearish GF Value perspective and potential support from institutional accumulation. Investors focused on valuation should monitor whether MLAB's premium persists or narrows as the company's fundamentals evolve within the Technology sector. - MESA LABS DECLARES QUARTERLY DIVIDEND (manilatimes.net, 2026-10-09)
TickrTrends take: Mesa Labs announced a quarterly dividend declaration, which represents a commitment to returning capital to shareholders on a regular basis. For investors focused on valuation metrics, the sustainability of this dividend relative to the company's cash generation and earnings will be an important factor to monitor, particularly given TickrTrends' assessment that the stock is fairly valued. A dividend-paying technology company trading at fair value may appeal to investors seeking both growth potential and income, though the dividend payout ratio and its growth trajectory warrant observation alongside any changes in the underlying business fundamentals. - Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors (gurufocus.com, 2026-09-03)
TickrTrends take: Mesa Laboratories Inc operates in the Technology sector and recently experienced a share price movement of 4% according to the most recent data. The company currently carries a GF Score of 75, which reflects a moderately strong fundamental assessment. With TickrTrends awaiting full valuation analysis for MLAB, investors focused on valuation metrics should monitor how the company's fundamentals align with its current market pricing as additional analysis develops.
What people are saying
Follow the MLAB conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-26 — TickrTrends' derived indicators for MLAB show a shift in valuation positioning this week. The sector discount rank moved from 113 to 122, indicating the stock is receiving less of a valuation discount relative to other technology sector companies. The valuation verdict has changed from Undervalued to Fairly valued, reflecting a reassessment of MLAB's current price relative to its fundamental metrics.
- 2026-10-19 — MLAB in the Technology sector has shifted to an Undervalued status this week, moving down in sector discount ranking from position 107 to position 113. The company's valuation verdict improved from Fairly valued to Undervalued according to TickrTrends' derived indicators.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — TickrTrends' derived indicators for MLAB show that the company's sector discount rank improved this week, moving from #112 to #107 among Technology sector peers. With a current valuation verdict of Fairly valued, MLAB has strengthened its relative position within its sector classification.
- 2026-10-05 — MLAB's sector discount rank improved this week, moving from 122 to 112 among Technology sector companies. This change reflects a shift in the stock's relative valuation positioning within its industry. The stock maintains a Fairly valued assessment.
- 2026-09-28 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-21 — TickrTrends' derived indicators for MLAB shifted from an awaiting full valuation status to a fairly valued assessment this week. The stock, which operates in the Technology sector, now reflects a valuation verdict that suggests its current price aligns reasonably with fundamental measures of value.
Frequently asked questions
Is MLAB stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-26), MLAB is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is MLAB's TickrTrends verdict?
MLAB's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does MLAB compare to other Technology stocks?
MLAB ranks #89 of 182 Technology stocks in TickrTrends' coverage by discount to fair value.
Is MLAB overbought or oversold?
MLAB's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does MLAB pay a dividend?
Yes. MLAB paid $0.64 per share over the last twelve months (4 payments), a 0.50% yield on TickrTrends' last price. The next ex-dividend date on file is 2026-11-30.
When does MLAB report earnings next?
MLAB's next earnings report is scheduled for 2026-11-05, per the published earnings calendar.
Does MLAB usually beat earnings estimates?
Over its last 8 reported quarters MLAB beat the consensus estimate 5 times and missed 3 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about MLAB?
Of 3 analysts covering MLAB, 1 rate it a buy, 2 a hold and 0 a sell - hold-leaning, with a consensus price target of $125 (-2.8% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Technology
Head-to-head comparisons
MLAB vs APH · MLAB vs CCSI · MLAB vs JBL · MLAB vs LRCX · MLAB vs MSI